Lyophillization of Liposomes for Pulmonary Administration
Abstract
Sildenafil citrate has become, in recent years, an oral therapeutic agent used for the treatment of arterial hypertension. Because it has certain limitations, such as a significant reduction in oral bioavailability and pharmacological activity due to first-pass hepatic metabolism, innovative formulations have been proposed for pulmonary administration. This allows minimising systemic adverse effects and the first-pass effect.
The aim of the work is to elaborate sildenafil-loaded liposomes and subsequently lyophilise them. Furthermore, to evaluate the flow properties of the solid product obtained for possible pulmonary administration.
The liposomes obtained were prepared using the sonication-filtration method, in the absence of organic solvents, and are therefore considered to be biocompatible and biodegradable systems, highly suitable for possible pulmonary administration. They showed high sildenafil encapsulation efficiency (EE% = 85).
Adequate solid product flow results were observed with each of the lyoprotectants used, obtaining angle of repose values below 30º and Carr’s index (CI) also below 36 %.
Therefore, lyophilisation of liposomes plays a fundamental role in the preservation and stability of these vesicles.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
Barnett CF, Machado RF. Sildenafil in the treatment of pulmonary hypertension. Vascular Health and Risk Management. 2006; 2(4):411-422.
Beltrán-Gámez M et al. Inhibidores de fosfodiesterasa-5 para el tratamiento de la hipertensión arterial pulmonar. Archivos Cardiología México. 2015; 85(3):215-224.
Blanco O et al. Viscosidad y Tamaño de Partícula de Una Preparación Clínica de Surfactante Pulmonar. Lat. Am. J. Pharm. 2008; 27(5):826-830.
De Jesús Valle MJ et al. Lyoprotective Effects of Mannitol and Lactose Compared to Sucrose and Trehalose: Sildenafil Citrate Liposomes as a Case Study. Pharmaceutics 2021; 13(8):1164.
De Jesús Valle MJ et al. Sildenafil Citrate Liposomes for Pulmonary Delivery by Ultrasonic Nebulization. Applied Sciences 2018; 8(8):1291.
Gaspar MM et al. Inhaled Liposomes-Current Strategies and Future Challenges. J Biomed Nanotechnol. 2008; 4(3):245-257.
Gavira Heredia FJ. Preparación de liposomas biocompatibles. Ventaja de su utilización en tratamientos contra el cáncer [Trabajo Fin de Grado]. Sevilla. Universidad de Sevilla; 2020.
Haque S et al. Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges. Nanomedicine Nanotechnology, Biol. Med. 2016; 12:1703-1724.
Lanio ME et al. Las vesículas liposomales: obtención, propiedades y aplicaciones potenciales en la biomedicina. Rev. Cubana. Fis. 2009; 26(1):23-30.
Marti?nez Pacheco R. Reología de sólidos pulverulentos. En: Martínez Pacheco R, editor. Tratado de Tecnologi?a Farmace?utica. Vol. I. Sistemas farmacéuticos. Madrid: Síntesis; 2016. p. 93-111.
Navarro G. Diseño de liposomas para el transporte de diclofenaco sódico Rev. Colomb. Cienc. Quim. Farm. 2008; 37(2):212-223.
Rosas RMJR et al. Sildenafil e inhibidores de fosfodiesterasa en hipertensión pulmonar. Neumol Cir Torax. 2006; 65(4):186-200.
Saharan VA. Chapter 2: Freeze drying technologies for developing fast dissolving/disintegrating tablets. En: Saharan VA, editor. Current Advances in Drug Delivery Through Fast Dissolving/Dissintegrating Dosage Forms. Sharjah, UAE: Bentham Science Publishers; 2017. p. 35-56.
Suñé Negre JM. Nuevas aportaciones galénicas a las formas de administración. Formación continuada para farmacéuticos del hospital. Disponible en: http://www.ub.edu/legmh/capitols/sunyenegre.pdf
Zakharova AA et al. Phosphodiesterase type 5 inhibitors greatly affect physicochemical properties of model lipid membranes. Membranes (Basel). 2021; 11(11):893.
Similar Articles
- Azahara I. Toro, María José de Jesús Valle, Drug delivery from liposomes in different biorelevant media , FarmaJournal: Vol. 6 No. 1 (2021)
- Jimena Barbero, Amparo Sánchez Navarro, María José de Jesús-Valle, Ergosterol Liposomes in Lyophilized Formulations for Buccal Administration , FarmaJournal: Vol. 9 No. 2 (2024)
- Laura Garrido de Gracia, María José de Jesús Valle, Aránzazu Zarzuelo Castañeda, Amparo Sánchez Navarro, Development of Mucoadhesive Oral Formulations Based on Resveratrol Liposomes , FarmaJournal: Vol. 10 No. 2 (2025)
- Oscar Delgado-Rubio, María José De Jesus-valle, Amparo Sanchez-Navarro, Design of a liposomal formulation aimed to vaccines administration , FarmaJournal: Vol. 1 No. 1 (2016)
- Diego Gallego, Clara Isabel Colino, Formulation and Optimization of Lipid Nanoparticles with Chitosan for Quercetin Delivery , FarmaJournal: Vol. 8 No. 2 (2023)
- María José Sanchez-Carpintero, Amparo Sanchez-Navarro, María José De Jesus-valle, Liposomes isolation and characterization by microencapsulation , FarmaJournal: Vol. 1 No. 1 (2016)
- Juan José Duque Aguilar, María José Jesús Del Valle, Amparo Sánchez Navarro, Microencapsulation of ciprofloxacin in microspheres of albumin and liposomes (Albusomes) , FarmaJournal: Vol. 2 No. 2 (2017)
- Javier Iglesias Colino, David García González, Miriam Flores Fernández, Pilar González Pérez, Miguel García Sanz, Alejandro Sanz Ruiz, Juan José Ortiz De Urbina González, Therapeutic drug monitoring of serum concentrations of abiraterone , FarmaJournal: Vol. 11 No. 1 (2026)
- Sara Viruega-Encinas, María José De Jesús-valle, Microencapsulation of antifungal agents in albumin coated liposomes , FarmaJournal: Vol. 2 No. 2 (2017)
- Cecilia Martín, Eduardo Arnáez, Lucía Velasco, Effectiveness and Safety of Pirfenidone Treatment in Patients with Idiopathic Pulmonary Fibrosis , FarmaJournal: Vol. 2 No. 1 (2017)
You may also start an advanced similarity search for this article.